Pharmafile Logo

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893

 Latest Content from PMHub 

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

Press Releases | December 3, 2016 | M3 (EU)

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...

Telehealth Research

White Papers and Resources | December 1, 2016 | Inizio

The remote exchange of data between patients and their clinician

Leading Edge expands their senior medical writing team

Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has bolstered its senior medical writing team with the new appointment of Jennifer (Jennie) Badger. Jennie...

Web Summit Lisbon: Technology trends that will impact pharma

Digital technology is transforming every aspect of life. Here’s the most important trends pharma companies should watch, as observed by Anthill at Websummit earlier this month:

Living with Crohn’s disease: a patient perspective

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for...

Lucid win PMEA Support Agency of the Year 2016

Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...

Case Study: Understanding the patient journey and addiction treatment pathways

White Papers and Resources | November 23, 2016 | Inizio

Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and...

Research Partnership has published a new Living with Chronic Pain market report for 2016

White Papers and Resources | November 23, 2016 | Inizio

Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients...

Nutraceuticals: Rich in Potential

White Papers and Resources | November 23, 2016 | Inizio

Published in eyeforpharma October 2016 by Marc Yates

Case Study: Qualitative research with payers in low and middle income countries

White Papers and Resources | November 23, 2016 | Inizio

Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...